Home › Companies › NOVAVAX INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and NOVAVAX INC.’s Form 8-K, filed July 11, 2023 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of July 11, 2023: 7 items on NOVAVAX INC.’s Form 8-K, filed July 11, 2023: 3 elected · 3 approved · 1 not approved.
Meeting of June 13, 2024: 7 items on NOVAVAX INC.’s Form 8-K, filed June 14, 2024: 3 elected · 4 approved.
Significant dissent: 5 directors (47.0%, 46.5%, 40.8%, 39.8%, 30.1% against).
Notable dissent: 5 other board items (48.3%, 30.2%, 26.4%, 20.2%, 16.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Shah Capital (13D, 6.5%, as of October 16, 2026)
Explore NOVAVAX INC. in the interactive database Compare manager voting policies
These tallies are NOVAVAX INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 11, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. NOVAVAX INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: John C. Jacobs | 18,096,901 | 881,806 | 285,358 | -- | 24,476,819 | 95% | Elected | — |
| Elect Director: Gregg H. Alton, J.D. | 11,319,429 | 7,498,303 | 446,333 | -- | 24,476,819 | 60% | Elected | — |
| Elect Director: Richard J. Rodgers | 13,138,940 | 5,662,283 | 462,842 | -- | 24,476,819 | 70% | Elected | — |
| 2. The compensation paid to the Company's named executive officers in 2022 | 15,695,578 | 3,030,052 | 538,435 | -- | 24,476,819 | 84% | Approved | — |
| 4. The amendment to the Second Amended and Restated Certificate of Incorporation of Novavax, Inc | 16,746,786 | 2,058,948 | 458,331 | -- | 24,476,819 | 89% | Not approved A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it. | — |
| 5. The amendment and restatement of the Novavax Inc | 15,131,768 | 3,824,183 | 308,114 | -- | 24,476,819 | 80% | Approved | — |
| 6. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 | 41,350,254 | 2,005,826 | 384,804 | -- | -- | 95% | Approved | — |
Source: NOVAVAX INC., Form 8-K, filed with the SEC on July 11, 2023 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Richard H. Douglas, Ph.D. | 25,482,021 | 17,594,381 | 813,977 | -- | 31,869,802 | 59% | Elected | — |
| Elect Director: Margaret G. McGlynn | 22,863,609 | 20,289,783 | 736,987 | -- | 31,869,802 | 53.0% | Elected | — |
| Elect Director: David Mott | 23,071,117 | 20,040,155 | 779,107 | -- | 31,869,802 | 53.5% | Elected | — |
| 2. The compensation paid to the Company's named executive officers in 2023 | 24,187,672 | 8,695,357 | 11,007,350 | -- | 31,869,802 | 74% | Approved | — |
| 3. The amendment and restatement of the Novavax, Inc | 22,436,050 | 20,948,176 | 506,153 | -- | 31,869,802 | 51.7% | Approved | — |
| 4. The amendment and restatement of the Novavax, Inc | 23,175,855 | 10,022,324 | 10,692,200 | -- | 31,869,802 | 70% | Approved | — |
| 5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 68,992,887 | 4,249,891 | 2,517,403 | -- | -- | 94% | Approved | — |
Source: NOVAVAX INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
313 asset managers disclosed a vote on at least one NOVAVAX INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NOVAVAX INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held July 11, 2023.
Combines 4 wordings of this item as funds reported it.
60% Majority: yes · of votes cast
Description as filed by funds: Election of Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders: Gregg H. Alton. J.D.
NOVAVAX INC.’s own tally for this item (“Elect Director: Gregg H. Alton, J.D.”): 11,319,429 for, 7,498,303 against, per its Form 8-K filed July 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results of the Annual Meeting are as follows: Proposal 1 : Stockholders elected the following Class I nominees for director, each to serve a three-year term expiring at the 2026 Annual Meeting of Stockholders:”
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 2,396,014 for, 957,976 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 0 | 934,293 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Fidelity | 56,918 | 0 | 0 | 0 | For |
| Federated Hermes | 56,351 | 0 | 0 | 0 | For |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 19,415 | 0 | 0 | 0 | For |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 1,233 | 14,227 | 0 | 0 | Mixed |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 3,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 3,197 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 0 | 2,416 | 0 | 0 | Against |
| Invesco | 0 | 1,931 | 0 | 0 | Against |
| JPMorgan | 1,492 | 0 | 0 | 0 | For |
| American Century | 1,484 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 1,412 | 0 | 0 | Against |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held July 11, 2023.
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders: John C. Jacobs
NOVAVAX INC.’s own tally for this item (“Elect Director: John C. Jacobs”): 18,096,901 for, 881,806 against, per its Form 8-K filed July 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results of the Annual Meeting are as follows: Proposal 1 : Stockholders elected the following Class I nominees for director, each to serve a three-year term expiring at the 2026 Annual Meeting of Stockholders:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,353,990 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 934,293 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Fidelity | 56,918 | 0 | 0 | 0 | For |
| Federated Hermes | 56,351 | 0 | 0 | 0 | For |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 19,415 | 0 | 0 | 0 | For |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 15,460 | 0 | 0 | 0 | For |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 3,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,197 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 2,416 | 0 | 0 | 0 | For |
| Invesco | 1,931 | 0 | 0 | 0 | For |
| JPMorgan | 1,492 | 0 | 0 | 0 | For |
| American Century | 1,484 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,412 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held July 11, 2023.
Combines 4 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: Election of Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders: Richard J. Rodgers
NOVAVAX INC.’s own tally for this item (“Elect Director: Richard J. Rodgers”): 13,138,940 for, 5,662,283 against, per its Form 8-K filed July 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results of the Annual Meeting are as follows: Proposal 1 : Stockholders elected the following Class I nominees for director, each to serve a three-year term expiring at the 2026 Annual Meeting of Stockholders:”
Support: 70% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,297,486 for, 56,504 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 934,293 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Fidelity | 56,918 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 56,351 | 0 | 0 | Against |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 19,415 | 0 | 0 | 0 | For |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 15,460 | 0 | 0 | 0 | For |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 3,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,197 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 2,416 | 0 | 0 | 0 | For |
| Invesco | 1,931 | 0 | 0 | 0 | For |
| JPMorgan | 1,492 | 0 | 0 | 0 | For |
| American Century | 1,484 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,412 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held June 13, 2024.
Combines 2 wordings of this item as funds reported it.
53.5% Majority: yes · of votes cast
Description as filed by funds: Election of Class II directors to serve on the Board of Directors, each for a three-year term expiring at the 2027 Annual Meeting of Stockholders: David Mott
NOVAVAX INC.’s own tally for this item (“Elect Director: David Mott”): 23,071,117 for, 20,040,155 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results of the Annual Meeting are as follows: Proposal 1 : Stockholders elected the following Class II nominees for director, each to serve a three-year term expiring at the 2027 Annual Meeting of Stockholders:”
Support: 53.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 1,513,733 for, 1,475,476 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 3,250 | 1,395,150 | 0 | 0 | Against |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 109,630 | 0 | 0 | 0 | For |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,529 | 73,600 | 0 | 0 | Mixed |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| Global X | 41,465 | 0 | 0 | 0 | For |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 37,978 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,480 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 11,298 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 3,200 | 0 | 0 | Against |
| TIAA | 2,627 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Meeting held June 13, 2024.
Combines 3 wordings of this item as funds reported it.
53.0% Majority: yes · of votes cast
Description as filed by funds: Election of Class II directors to serve on the Board of Directors, each for a three-year term expiring at the 2027 Annual Meeting of Stockholders: Margaret G. McGlynn, R.Ph.
NOVAVAX INC.’s own tally for this item (“Elect Director: Margaret G. McGlynn”): 22,863,609 for, 20,289,783 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results of the Annual Meeting are as follows: Proposal 1 : Stockholders elected the following Class II nominees for director, each to serve a three-year term expiring at the 2027 Annual Meeting of Stockholders:”
Support: 53.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 1,437,650 for, 1,551,559 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 3,070 | 1,395,330 | 0 | 0 | Against |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 109,630 | 0 | 0 | 0 | For |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,529 | 73,600 | 0 | 0 | Mixed |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| Global X | 0 | 41,465 | 0 | 0 | Against |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 15,261 | 22,717 | 0 | 0 | Mixed |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,480 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 0 | 11,298 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 0 | 3,200 | 0 | 0 | Against |
| TIAA | 2,627 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Meeting held June 13, 2024.
Combines 2 wordings of this item as funds reported it.
59% Majority: yes · of votes cast
Description as filed by funds: Election of Class II directors to serve on the Board of Directors, each for a three-year term expiring at the 2027 Annual Meeting of Stockholders: Richard H. Douglas, Ph.D.
NOVAVAX INC.’s own tally for this item (“Elect Director: Richard H. Douglas, Ph.D.”): 25,482,021 for, 17,594,381 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results of the Annual Meeting are as follows: Proposal 1 : Stockholders elected the following Class II nominees for director, each to serve a three-year term expiring at the 2027 Annual Meeting of Stockholders:”
Support: 59% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 2,985,280 for, 3,929 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 1,398,029 | 371 | 0 | 0 | For |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 109,630 | 0 | 0 | 0 | For |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 96,129 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| Global X | 41,465 | 0 | 0 | 0 | For |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 37,978 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,480 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 11,298 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,200 | 0 | 0 | 0 | For |
| TIAA | 2,627 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Meeting held July 11, 2023.
Combines 2 wordings of this item as funds reported it.
89% Not approved · of votes cast
Description as filed by funds: AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NOVAVAX, INC., AS AMENDED, TO REFLECT DELAWARE LAW PROVISIONS ALLOWING OFFICER EXCULPATION.
NOVAVAX INC.’s own tally for this item (“4. The amendment to the Second Amended and Restated Certificate of Incorporation of Novavax, Inc”): 16,746,786 for, 2,058,948 against — failed, per its Form 8-K filed July 11, 2023 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “Proposal 4 : Stockholders did not approve the amendment to the Second Amended and Restated Certificate of Incorporation of Novavax, Inc. to reflect Delaware law provisions allowing officer exculpation:”
A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,191,701 for, 162,289 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 934,293 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 80,058 | 0 | 0 | Against |
| Fidelity | 56,918 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 56,351 | 0 | 0 | Against |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 19,415 | 0 | 0 | Against |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 15,460 | 0 | 0 | 0 | For |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 3,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,197 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 2,416 | 0 | 0 | 0 | For |
| Invesco | 1,931 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 1,492 | 0 | 0 | Against |
| American Century | 1,484 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,412 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held July 11, 2023.
Combines 3 wordings of this item as funds reported it.
80% Approved · of votes cast
Description as filed by funds: Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentve Plan, as amended to increase the number of shares of common stock available for issuance thereunder by 6,170,000 shares.
NOVAVAX INC.’s own tally for this item (“5. The amendment and restatement of the Novavax Inc”): 15,131,768 for, 3,824,183 against — passed, per its Form 8-K filed July 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5 : Stockholders approved the amendment and restatement of the Novavax Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares of Common Stock available for issuance thereunder by 6,170,000 shares:”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 3,333,918 for, 20,172 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 934,293 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Fidelity | 41,683 | 15,235 | 0 | 0 | Mixed |
| Federated Hermes | 56,351 | 0 | 0 | 0 | For |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 19,415 | 0 | 0 | 0 | For |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 15,460 | 0 | 0 | 0 | For |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 3,300 | 0 | 0 | Against |
| Goldman Sachs | 3,197 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 2,416 | 0 | 0 | 0 | For |
| Invesco | 1,931 | 0 | 0 | 0 | For |
| JPMorgan | 1,492 | 0 | 0 | 0 | For |
| American Century | 0 | 1,484 | 0 | 0 | Against |
| T. Rowe Price | 1,412 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. All 54 are in the interactive database (link above).
Meeting held June 13, 2024.
Combines 3 wordings of this item as funds reported it.
99.5% of fund votes cast · no official result
Description as filed by funds: Amendment and Restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 6,500,000 shares.
The 47 asset managers below reported 2,973,941 for, 15,368 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 1,398,180 | 220 | 0 | 0 | For |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 109,630 | 0 | 0 | 0 | For |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 96,129 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| Global X | 41,465 | 0 | 0 | 0 | For |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 37,978 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,480 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 0 | 11,298 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,200 | 0 | 0 | 0 | For |
| TIAA | 2,627 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Meeting held June 13, 2024.
Combines 2 wordings of this item as funds reported it.
93% of fund votes cast · no official result
Description as filed by funds: Amendment and restatement of the Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,000,000 shares, such that the number of shares available for issuance thereunder is the lesser of (a) 2,155,000 shares of common stock increased on January 1 of each year by 5% of the share pool on such January 1 (rounded down to the nearest whole share) and (b) 3,510,264 shares of common stock.
The 46 asset managers below reported 2,785,870 for, 203,439 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 1,398,400 | 0 | 0 | 0 | For |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 109,630 | 0 | 0 | Against |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 96,129 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 49,231 | 0 | 0 | Against |
| Global X | 0 | 41,465 | 0 | 0 | Against |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 37,978 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,480 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 11,298 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,200 | 0 | 0 | 0 | For |
| TIAA | 2,627 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).
Meeting held July 11, 2023.
Combines 7 wordings of this item as funds reported it.
84% Approved · of votes cast
Description as filed by funds: The approval, on an advisory basis, of the compensation paid to our Named Executive Officers.
NOVAVAX INC.’s own tally for this item (“2. The compensation paid to the Company's named executive officers in 2022”): 15,695,578 for, 3,030,052 against — passed, per its Form 8-K filed July 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 : Stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers in 2022:”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 934,293 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Fidelity | 56,918 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 56,351 | 0 | 0 | Against |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 19,415 | 0 | 0 | Against |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 15,460 | 0 | 0 | 0 | For |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 3,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,197 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 2,416 | 0 | 0 | 0 | For |
| Invesco | 1,931 | 0 | 0 | 0 | For |
| JPMorgan | 1,492 | 0 | 0 | 0 | For |
| American Century | 1,484 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,412 | 0 | 0 | 0 | For |
Fund voting reports, all 50 managers: 3,272,991 for, 80,392 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Paragon Capital Management LLC | 5,000,000 | 0 | 0 | 0 | For |
| State Street | 1,533,294 | 0 | 0 | 0 | For |
| Janus Henderson | 1,000,000 | 0 | 0 | 0 | For |
| BlackRock | 776,729 | 10,485 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 495,473 | 0 | 0 | 0 | For |
| Vanguard | 230,804 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 142,486 | 0 | 0 | Against |
| Rhumbline | 72,322 | 0 | 0 | 0 | For |
| UBS | 0 | 92,511 | 0 | 0 | Against |
| COATUE MANAGEMENT LLC | 91,114 | 0 | 0 | 0 | For |
| Northern Trust | 81,940 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 69,599 | 0 | 0 | Against |
| Rock Springs Capital Management LP | 67,107 | 0 | 0 | 0 | For |
| AllianceBernstein | 63,531 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 58,881 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 50,586 | 0 | 0 | 0 | For |
| West Coast Financial LLC | 45,825 | 0 | 0 | 0 | For |
| T. Rowe Price | 39,650 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 27,236 | 0 | 0 | 0 | For |
| SEI | 0 | 27,022 | 0 | 0 | Against |
| Cresset Asset Management, LLC | 25,761 | 0 | 0 | 0 | For |
| ONTARIO TEACHERS PENSION PLAN BOARD | 0 | 25,084 | 0 | 0 | Against |
| OPPENHEIMER & CO INC | 0 | 23,667 | 0 | 0 | Against |
| Goldman Sachs | 23,167 | 0 | 0 | 0 | For |
Institutional-manager reports, all 209 managers: 10,037,598 for, 484,154 against, 35 not voted, 42,743 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held July 11, 2023.
Combines 5 wordings of this item as funds reported it.
96% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: The approval, on an advisory basis, of holding future executive compensation advisory votes every three years, every two years, or every year.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Guggenheim | 0 | 0 | 0 | 0 | -- |
| Amplify ETF Trust | 0 | 0 | 0 | 0 | -- |
| MFS | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Morgan Stanley | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Humankind Benefit Corp | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 50 managers: 3,353,297 1 year, 86 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Paragon Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Rafferty Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 72,322 | 0 | 0 | 0 | For |
| UBS | 0 | 0 | 0 | 0 | -- |
| COATUE MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Rock Springs Capital Management LP | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| West Coast Financial LLC | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Cresset Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| ONTARIO TEACHERS PENSION PLAN BOARD | 0 | 0 | 0 | 0 | -- |
| OPPENHEIMER & CO INC | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 204 managers: 75,480 for, 2,749 against, 35 not voted, 10,462,798 1 year, 5,882 3 year, 107 unknown, 60 2 year. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held June 13, 2024.
Combines 8 wordings of this item as funds reported it.
74% Approved · of votes cast
Description as filed by funds: The approval, on an advisory basis, of the compensation paid to our Named Executive Officers.
NOVAVAX INC.’s own tally for this item (“2. The compensation paid to the Company's named executive officers in 2023”): 24,187,672 for, 8,695,357 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 : Stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers in 2023:”
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 1,398,400 | 0 | 0 | 0 | For |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 109,630 | 0 | 0 | 0 | For |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 96,129 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| Global X | 41,465 | 0 | 0 | 0 | For |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 24,914 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,479 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 0 | 11,298 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,200 | 0 | 0 | 0 | For |
| TIAA | 2,181 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Fund voting reports, all 42 managers: 2,960,730 for, 13,483 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 2,365,440 | 0 | 0 | 0 | For |
| BlackRock | 674,846 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 537,625 | 0 | 0 | 0 | For |
| Northern Trust | 503,888 | 0 | 0 | 0 | For |
| Monaco Asset Management SAM | 0 | 387,564 | 0 | 0 | Against |
| Vestal Point Capital, LP | 277,486 | 0 | 0 | 0 | For |
| PACIFIC INVESTMENT MANAGEMENT CO LLC | 190,501 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 188,150 | 0 | 0 | 0 | For |
| Vanguard | 177,867 | 0 | 0 | 0 | For |
| Citadel | 167,377 | 0 | 0 | 0 | For |
| JPMorgan | 126,337 | 0 | 0 | 0 | For |
| UBS | 0 | 116,536 | 0 | 0 | Against |
| Charles Schwab | 109,651 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 107,345 | 0 | 0 | 0 | For |
| DE Shaw | 95,961 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 94,593 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 89,180 | 0 | 0 | 0 | For |
| Goldman Sachs | 79,026 | 0 | 0 | 0 | For |
| T. Rowe Price | 74,079 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 53,292 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| West Coast Financial LLC | 45,625 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 43,600 | 0 | 0 | 0 | For |
| Mitsubishi UFJ Asset Management Co., Ltd. | 41,525 | 0 | 0 | 0 | For |
Institutional-manager reports, all 182 managers: 6,668,926 for, 593,097 against, 1 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held July 11, 2023.
Combines 3 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2023.
NOVAVAX INC.’s own tally for this item (“6. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023”): 41,350,254 for, 2,005,826 against — passed, per its Form 8-K filed July 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 6 : Stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,351,109 for, 2,881 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,531,171 | 0 | 0 | 0 | For |
| State Street | 934,293 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 495,473 | 0 | 0 | 0 | For |
| Charles Schwab | 80,058 | 0 | 0 | 0 | For |
| Fidelity | 56,918 | 0 | 0 | 0 | For |
| Federated Hermes | 56,351 | 0 | 0 | 0 | For |
| BlackRock | 44,074 | 0 | 0 | 0 | For |
| Guggenheim | 22,166 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 19,415 | 0 | 0 | 0 | For |
| MFS | 18,243 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,939 | 0 | 0 | 0 | For |
| Equitable | 15,460 | 0 | 0 | 0 | For |
| Voya | 10,692 | 0 | 0 | 0 | For |
| Pacific Life | 6,833 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 5,678 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,784 | 0 | 0 | 0 | For |
| Aberdeen | 3,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,197 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 2,799 | 0 | 0 | 0 | For |
| TIAA | 2,604 | 0 | 0 | 0 | For |
| Humankind Benefit Corp | 0 | 2,416 | 0 | 0 | Against |
| Invesco | 1,931 | 0 | 0 | 0 | For |
| JPMorgan | 1,492 | 0 | 0 | 0 | For |
| American Century | 1,484 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,412 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held June 13, 2024.
Combines 2 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
NOVAVAX INC.’s own tally for this item (“5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 68,992,887 for, 4,249,891 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5 : Stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 2,986,623 for, 2,586 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 1,398,180 | 220 | 0 | 0 | For |
| Vanguard | 455,267 | 0 | 0 | 0 | For |
| BlackRock | 338,246 | 0 | 0 | 0 | For |
| Charles Schwab | 109,630 | 0 | 0 | 0 | For |
| Fidelity | 102,454 | 0 | 0 | 0 | For |
| Lincoln Financial | 96,129 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 94,593 | 0 | 0 | 0 | For |
| Aberdeen | 63,800 | 0 | 0 | 0 | For |
| Federated Hermes | 49,231 | 0 | 0 | 0 | For |
| Global X | 41,465 | 0 | 0 | 0 | For |
| Pacific Life | 39,754 | 0 | 0 | 0 | For |
| Equitable | 37,978 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,449 | 0 | 0 | 0 | For |
| Guggenheim | 24,368 | 0 | 0 | 0 | For |
| ProShares | 20,480 | 0 | 0 | 0 | For |
| John Hancock | 18,793 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 14,980 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,726 | 0 | 0 | 0 | For |
| Calvert | 11,298 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 7,007 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,023 | 0 | 0 | 0 | For |
| Principal | 4,133 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 3,200 | 0 | 0 | 0 | For |
| TIAA | 2,627 | 0 | 0 | 0 | For |
| JPMorgan | 1,754 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of June 20, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 94,308,379 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 1.62% |
| 2 | State Street | 0.99% |
| 3 | Direxion Shares ETF Trust | 0.53% |
| 4 | Charles Schwab | 0.08% |
| 5 | Fidelity | 0.06% |
| 6 | Federated Hermes | 0.06% |
| 7 | BlackRock | 0.05% |
| 8 | Guggenheim | 0.02% |
| 9 | Amplify ETF Trust | 0.02% |
| 10 | MFS | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Paragon Capital Management LLC | 5.30% |
| 2 | State Street | 1.63% |
| 3 | Janus Henderson | 1.06% |
| 4 | BlackRock | 0.83% |
| 5 | Rafferty Asset Management, LLC | 0.53% |
| 6 | Vanguard | 0.24% |
| 7 | PNC BANK, NATIONAL ASSOCIATION | 0.15% |
| 8 | Rhumbline | 0.12% |
| 9 | UBS | 0.10% |
| 10 | COATUE MANAGEMENT LLC | 0.10% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| State Street Corporation | 16,775,875 | 17.79% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| Vanguard Group | 15,194,563 | 16.11% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 12,773,053 | 13.54% | Form 13F, quarter ended March 31, 2024 |
| Shah Capital Management | 9,383,335 | 9.95% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| Geode Capital | 2,587,734 | 2.74% | Form 13F, quarter ended March 31, 2024 |
| Citadel Advisors | 1,588,351 | 1.68% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 1,164,076 | 1.23% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 1,064,760 | 1.13% | Form 13F, quarter ended March 31, 2024 |
| Charles Schwab | 930,220 | 0.99% | Form 13F, quarter ended March 31, 2024 |
| Stanley C. Erck | 876,206 | 0.93% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
Percentages above are of 94,308,379 shares outstanding, as reported by NOVAVAX INC. on its Form 10-Q dated June 30, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At NOVAVAX INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held July 11, 2023 and June 13, 2024), 313 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,980 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held July 11, 2023 — The approval, on an advisory basis, of the compensation paid to our Named Executive Officers. — NOVAVAX INC.'s filing reports the proposal as approved, with 84% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NOVAVAX INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 11, 2023.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NOVAVAX INC.’s 10-Q dated June 30, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
NOVAVAX INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “NOVAVAX (NVAX) 2023-2024 Annual Meetings: Shareholder Vote Results”, https://proxyvotesnow.com/company/novavax-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.